Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours

por Campone, M, Levy, V, Bourbouloux, E, Berton Rigaud, D, Bootle, D, Dutreix, C, Zoellner, U, Shand, N, Calvo, F, Raymond, E
Publicado 2009

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracy...

por Campone, M, Cortes-Funes, H, Vorobiof, D, Martin, M, Slabber, C F, Ciruelos, E, Bourbouloux, E, Mendiola, C, Delgado, F M, Colin, C, Aslanis, V, Fumoleau, P
Publicado 2006

Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas

por Loussouarn, D, Campion, L, Sagan, C, Frenel, J-S, Dravet, F, Classe, J-M, Pioud-Martigny, R, Berton-Rigaud, D, Bourbouloux, E, Mosnier, J-F, Bataille, F-R, Campone, M
Publicado 2008